Panaxia & Neuraxpharm Launch Medical Cannabis Extracts In Europe, More Products To Come
Panaxia Labs Israel Reports Q3 Record Revenues Of $7.15M, Up 34% YoY
Panaxia Q2 Revenue Grows 19.2% Reaching $5.49M, Sells Its Secondary Operations In Israel
Panaxia and Neuraxpharm To Exclusively Distribute Medical Cannabis Extracts For Inhalation In Europe